IMAC News and Press, IMAC Holdings Inc. From 10/26/21

T he Back Space Continues Its Pilot Store Program in the Nashville market BRENTWOOD, Tenn., Oct. 26, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”) today announces the comp...

RALEIGH, NC / ACCESSWIRE / October 4, 2021 / The Fall Harvest - Best Ideas from the Buy-Side will take place on October 5 th - 8 th , 2021, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience. The Fall Harvest - Best...

Allen Johnston, M.D. Joins IMAC as a Medical Director, Expanding Company’s Footprint, Expertise in Sports Medicine BRENTWOOD, Tenn, Oct. 04, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”)...

BRENTWOOD, Tenn, Sept. 28, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the us...

Brentwood, Tenn., Sept. 08, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”) has been invited to present at the Lake Street’s 5th Annual Best Ideas Growth (BIG5) Conference , which is being held virtua...

IMAC reports 36% increase in revenues and 70% increase in patient visits as it invests in value-generating assets BRENTWOOD, Tenn., Aug. 12, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative me...

International Media Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering on NASDAQ PR Newswire NEW YORK , July 28, 2021 /PRNewswire/ -- International Media Acquisition Corp. ("IMAC") announced today the pricing of its initial public of...

IMAC Holdings (IMAC) has initiated the second cohort of its Phase 1 clinical trial for investigational compound utilizing umbilical cord-derived allogenic mesenchymal stem cells for the treatment of bradykinesia due to Parkinson’s disease. The Phase 1 trial, consisting of a 15-patient ...

BRENTWOOD, Tenn, July 13, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), today announces it has initiated the second cohort of its Phase 1 clinical trial for its investigational compound utilizing umbilical cord-d...

T he Back Space Continues Its Successful Pilot Program in Tennessee, Expanding into St. Louis BRENTWOOD, Tenn., July 07, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”) today announces the ...